<DOC>
	<DOCNO>NCT03084185</DOCNO>
	<brief_summary>This single-center prospective study identify specific biomarker order predict development decompensation cirrhotic patient . The duration study 36 month provide cohort 200 patient .</brief_summary>
	<brief_title>Evaluation Role Plasma Biomarkers Development Decompensation Patients With Cirrhosis .</brief_title>
	<detailed_description>At screening , patient take blood sample perform hepatic vein pressure gradient . After randomization , patient see follow every 3 month blood sample every 12 month undergo hepatic vein pressure gradient , accord guideline . In addition , metabolomics analysis perform screen every 3 month . The result analyze relation emergence decompensation follow period , order identify specific metabolomics characteristic may able predict decompensation .</detailed_description>
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Liver Cirrhosis</mesh_term>
	<mesh_term>Hypertension , Portal</mesh_term>
	<criteria>Diagnosis liver cirrhosis Aged 18 75 year Obtaining write informed consent Absence exclusion criterion Diagnosis hepatocellular carcinoma Presence portal vein thrombosis HIV Liver transplantation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>decompensation</keyword>
	<keyword>deficit</keyword>
	<keyword>metabolomics</keyword>
	<keyword>portal hypertension</keyword>
</DOC>